{
    "id": "0210",
    "question": "An investigator is studying the effect of drug X on the retinoblastoma (Rb) gene on chromosome 13 in endometrial cells. Endometrial cells obtained from study participants are plated on growth media and the distribution of cell cycle phase is measured with flow cytometry. Drug X, which is known to activate cyclin-dependent kinase 4, is administered to all the cells, and the distribution of cell cycle phase is measured again 1 hour later. Which of the following is most likely to result from the action of drug X on the Rb gene?",
    "options": {
        "A": "G1 phase arrest",
        "B": "Prophase I arrest",
        "C": "Initiation of S phase",
        "D": "Completion of G2 phase"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"To solve this question, we need to understand the role of the retinoblastoma (Rb) gene and the effect of drug X on the cell cycle. The Rb gene is a tumor suppressor gene that regulates the cell cycle by binding to and inhibiting the E2F proteins, thus blocking progression to DNA replication and cell division. Drug X is known to activate cyclin-dependent kinase 4 (Cdk4), which phosphorylates and inactivates the Rb protein, allowing the cell to progress through the cell cycle. Given this information, let's analyze the options: A. G1 phase arrest: This option is incorrect because drug X is expected to activate Cdk4, which inactivates Rb, allowing the cell to progress through the cell cycle, not arrest in the G1 phase. B. Prophase I arrest: This option is incorrect because the cell cycle has only one prophase (proliferative phase), and drug X is expected to activate Cdk4, which inactivates Rb, allowing the cell to progress through the cell cycle, not arrest in prophase I. C. Initiation of S phase: This option is correct because drug X is expected to activate Cdk4, which inactivates Rb, allowing the cell to progress through the cell cycle and enter the S phase, where DNA replication occurs. D. Completion of G2 phase: This option is incorrect because drug X is expected to activate Cdk4, which inactivates Rb, allowing the cell to progress through the cell cycle and enter the S phase, not complete the G2 phase. Therefore, the most likely result from the action of drug X on the Rb gene is the initiation of S phase.\", \"answer_choice\": \"C\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_6093",
            "title": "InternalMed_Harrison",
            "content": "and Rb (discussed below). The progression of a cell through the cell division cycle is regulated at a number of checkpoints by a wide array of genes. In the first phase, G1, preparations are made to replicate the genetic material. The cell stops before entering the DNA synthesis phase, or S phase, to take inventory. Are we ready to replicate our DNA? Is the DNA repair machinery in place to fix any mutations that are detected? Are the DNA replicating enzymes available? Is there an adequate supply of nucleotides? Is there sufficient energy? The main brake on the process is the retinoblastoma protein, Rb. When the cell determines that it is prepared to move ahead, sequential activation of cyclin-dependent kinases (CDKs) results in the inactivation of the brake, Rb, by phosphorylation. Phosphorylated Rb releases the S phase\u2013regulating transcription factor, E2F/DP1, and genes required for S phase progression are expressed. If the cell determines that it is unready to move ahead with DNA"
        },
        {
            "id": "Cell_Biology_Alberts_5545",
            "title": "Cell_Biology_Alberts",
            "content": "The Rb gene is also missing in several common types of sporadic cancer, including carcinomas of lung, breast, and bladder. These more common cancers arise by a more complex series of genetic changes than does retinoblastoma, and they make their appearance much later in life. But in all of them, it seems, loss of Rb function is frequently a major step in the progression toward malignancy. The Rb gene encodes the Rb protein, which is a universal regulator of the cell cycle present in almost all cells of the body (see Figure 17\u201361). It acts as one of the main brakes on progress through the cell-division cycle, and its loss can allow cells to enter the cell cycle inappropriately, as we discuss later."
        },
        {
            "id": "Gynecology_Novak_478",
            "title": "Gynecology_Novak",
            "content": "Normal Cell Cycle Adult eukaryotic cells possess a well-balanced system of continuous production of DNA (transcription) and proteins (translation). Proteins are constantly degraded and replaced depending on the specific cellular requirements. Cells proceed through a sequence of phases called the cell cycle, during which the DNA is distributed to two daughter cells (mitosis) and subsequently duplicated (synthesis phase). This process is controlled at key checkpoints that monitor the status of a cell, for example, the amount of DNA present. The cell cycle is regulated by a small number of heterodimeric protein kinases that consist of a regulatory subunit (cyclin) and a catalytic subunit (cyclin-dependent kinase). Association of a cyclin with a cyclindependent kinase (CdkC) determines which proteins will be phosphorylated at a specific point during the cell cycle. Figure 6.2 The cell cycle."
        },
        {
            "id": "Gynecology_Novak_490",
            "title": "Gynecology_Novak",
            "content": "Cell Division Cycle Genes Among the factors that regulate the cell cycle checkpoints, proteins encoded by the cdc2 family of genes and the cyclin proteins appear to play particularly important roles (8,9). Growth factor\u2013stimulated mammalian cells express early-response or delayed-response genes, depending on the chronological sequence of the appearance of specific RNAs. The early-and delayed-response genes act as nuclear transcription factors and stimulate the expression of a cascade of other genes. Early-response genes such as c-Jun and c-Fos enhance the transcription of delayed-response genes such as E2Fs. E2F transcription factors are required for the expression of various cell cycle genes and are functionally regulated by the retinoblastoma (Rb) protein. Binding of Rb to E2F converts E2F from a transcriptional activator to a repressor of transcription. Phosphorylation of Rb inhibits its repressing function and permits E2F-mediated activation of genes required for entry into the S"
        },
        {
            "id": "Gynecology_Novak_491",
            "title": "Gynecology_Novak",
            "content": "E2F from a transcriptional activator to a repressor of transcription. Phosphorylation of Rb inhibits its repressing function and permits E2F-mediated activation of genes required for entry into the S phase. Cdk4-cyclin D, Cdk6-cyclin D, and Cdk2-cyclin E complexes cause phosphorylation of Rb, which remains phosphorylated throughout the S, G2, and M phases of the cell cycle. After completion of mitosis, a decline of the level of Cdk-cyclins leads to dephosphorylation of Rb by phosphatases and, consequently, an inhibition of E2F in the early G1 phase."
        },
        {
            "id": "Pathoma_Husain_67",
            "title": "Pathoma_Husain",
            "content": "v. Mutated ras inhibits the activity of GTPase activating protein. This prolongs the activated state of ras, resulting in increased growth signals. 4. Cell cycle regulators mediate progression through the cell cycle (e.g., cyclin and cyclin-dependent kinase). i. Cyclins and cyclin-dependent kinases (CDKs) form a complex which phosphorylates proteins that drive the cell through the cell cycle. ii. For example, the cyclinD/CDK4 complex phosphorylates the retinoblastoma protein, which promotes progression through the G/ S checkpoint. III. TUMOR SUPPRESSOR GENES A. Regulate cell growth and, hence, decrease (\"suppress\") the risk of tumor formation; p53 and Rb (retinoblastoma) are classic examples. B. p53 regulates progression of the cell cycle from G to S phase. Table 3.3: Important Oncogenes and Associated Tumors PDGFB Platelet-derived growth factor Overexpression, autocrine loop Astrocytoma"
        },
        {
            "id": "Cell_Biology_Alberts_5074",
            "title": "Cell_Biology_Alberts",
            "content": "A. Which cells in Figure Q17\u20131 are in the G1, S, G2, and M phases of the cell cycle? Explain the basis for your answer. b. Sketch the sorting distributions you would expect for cells that were treated with inhibitors that block the cell cycle in the G1, S, or M phase. Explain your reasoning. Figure Q17\u20131 analysis of Hoechst 33342 fluorescence in a population of cells sorted in a flow cytometer (problem 17\u20138). 17\u20139 The yeast cohesin subunit Scc1, which is essential for sister-chromatid cohesion, can be artificially regulated for expression at any point in the cell cycle. If expression is turned on at the beginning of S phase, all the cells divide satisfactorily and survive. By contrast, if Scc1 expression is turned on only after S phase is completed, the cells fail to divide and they die, even though Scc1 accumulates in the nucleus and interacts efficiently with chromosomes. Why do you suppose that cohesin must be present during S phase for cells to divide normally?"
        },
        {
            "id": "Pathology_Robbins_1251",
            "title": "Pathology_Robbins",
            "content": "http://ebooksmedicine.net The function of the RB protein is to regulate the G1/S checkpoint, the portal through which cells must pass before DNA replication commences. Although each phase of the cell cycle circuitry is monitored carefully, the transition from G1 to S is an extremely important checkpoint in the cell cycle \u201cclock.\u201d In the G1 phase, diverse signals are integrated to determine whether the cell should progress through the cell cycle, or exit the cell cycle and differentiate. The RB gene product, RB, is a DNA-binding protein that serves as a point of integration for these diverse signals, which ultimately act by altering the phosphorylation state of RB. Specifically, signals that promote cell cycle progression lead to the phosphorylation and inactivation of RB, while those that block cell cycle progression act by maintaining RB in an active hypophosphorylated state."
        },
        {
            "id": "Histology_Ross_480",
            "title": "Histology_Ross",
            "content": "It is now known that the cyclin\u2013Cdk complex acts at different phases of the cell cycle and targets different proteins to control cell-cycle\u2013dependent functions. Table 3.1 shows the combination of the different types of cyclins with different types of Cdks and how interactions between these two proteins affect cells progressing through the cell cycle. Passage through the cell cycle requires an increase in cyclin\u2013Cdk activity in some phases followed by the decline of that activity in other phases (Fig. 3.11). The increased activity of FIGURE 3.11 \u2022 Regulation of the cell cycle by cyclin\u2013Cdk complexes. This diagram shows the changing pattern of cyclin\u2013Cdk activities during different phases of the cell cycle. cyclin\u2013Cdk is achieved by the stimulatory action of cyclins and is counterbalanced by the inhibitory action of proteins such as Inks (inhibitors of kinase), Cips (Cdk inhibitory proteins), and Kips (kinase inhibitory proteins)."
        },
        {
            "id": "Cell_Biology_Alberts_5073",
            "title": "Cell_Biology_Alberts",
            "content": "17\u20136 If we could turn on telomerase activity in all our cells, we could prevent aging. Discuss the following problems. 17\u20137 Many cell-cycle genes from human cells function perfectly well when expressed in yeast cells. Why do you suppose that is considered remarkable? After all, many human genes encoding enzymes for metabolic reactions also function in yeast, and no one thinks that is remarkable. 17\u20138 Hoechst 33342 is a membrane-permeant dye that fluoresces when it binds to DNA. When a population of cells is incubated briefly with Hoechst dye and then sorted in a flow cytometer, which measures the fluorescence of each cell, the cells display various levels of fluorescence as shown in Figure Q17\u20131. A. Which cells in Figure Q17\u20131 are in the G1, S, G2, and M phases of the cell cycle? Explain the basis for your answer."
        },
        {
            "id": "InternalMed_Harrison_6310",
            "title": "InternalMed_Harrison",
            "content": "Direct DNA-iNterActive AgeNts DNA replication occurs during the synthesis or S-phase of the cell cycle, with chromosome segregation of the replicated DNA occurring in the M, or mitosis, phase. The G1 and G2 \u201cgap phases\u201d precede S and M, respectively. Historically, chemotherapeutic agents have been divided into \u201cphase-nonspecific\u201d agents, which can act in any phase of the cell cycle, and \u201cphase-specific\u201d agents, which require the cell to be at a particular cell cycle phase to cause greatest effect. Once the agent has acted, cells may progress to \u201ccheckpoints\u201d in the cell cycle where the drug-related damage may be assessed and either repaired or allowed to initiate apoptosis. An important function of certain tumor-suppressor genes such as p53 may be to modulate checkpoint function."
        },
        {
            "id": "Pathology_Robbins_1407",
            "title": "Pathology_Robbins",
            "content": "Oncogenic activities of E7. The E7 protein has effects that complement those of E6, all of which are centered on http://ebooksmedicine.net speeding cells through the G1-S cell cycle checkpoint. It binds to the RB protein and displaces the E2F transcription factors that are normally sequestered by RB, promoting progression through the cell cycle. As with E6 proteins and p53, E7 proteins from high-risk HPV types have a higher affinity for RB than do E7 proteins from low-risk HPV types. E7 also inactivates the CDK inhibitors p21 and p27, and binds and presumably activates cyclins E and A."
        },
        {
            "id": "Cell_Biology_Alberts_4849",
            "title": "Cell_Biology_Alberts",
            "content": "In the simple cell cycles of early animal embryos, gene transcription does not occur. Cell-cycle control depends exclusively on post-transcriptional mechanisms that involve the regulation of Cdks and ubiquitin ligases and their target proteins. In the more complex cell cycles of most cell types, however, transcriptional control provides an important additional level of regulation. Changes in cyclin gene transcription, for example, help control cyclin levels in most cells. A variety of methods discussed in Chapter 8 have been used to analyze changes in the expression of all genes in the genome as the cell progresses through the cell cycle. The results of these studies are surprising. In budding yeast, for example, about 10% of the genes encode mRNAs whose levels oscillate during the cell cycle. Some of these genes encode proteins with known cell-cycle functions, but the functions of many others are unknown. The Cell-Cycle Control system Functions as a network of Biochemical switches"
        },
        {
            "id": "Cell_Biology_Alberts_5587",
            "title": "Cell_Biology_Alberts",
            "content": "As discussed in Chapter 17, the p53 protein exerts its inhibitory effects on the cell cycle, in part at least, by inducing the transcription of p21, which encodes a protein that binds to and inhibits the cyclin-dependent kinase (Cdk) complexes required for progression through the cell cycle. By blocking the kinase activity of these Cdk complexes, the p21 protein prevents the cell from progressing through S phase and replicating its DNA. The mechanism by which p53 induces apoptosis includes stimulation of the expression of many pro-apoptotic genes, and it will be described in Chapter 18. If the p53 pathway is functional, a cell with unrepaired DNA damage will stop dividing or die; it cannot proliferate. Mutations in the p53 pathway are, therefore, generally present in cancer cells showing genome instability\u2014which is to say, the majority. But how does this genome instability originate? Here too, cancer genome studies are illuminating."
        },
        {
            "id": "Pathology_Robbins_1256",
            "title": "Pathology_Robbins",
            "content": "RB phosphorylation can mimic the effect of RB loss and are commonly found in many cancers that have normal RB genes. For example, mutational activation of CDK4 and overexpression of cyclin D favor cell proliferation by facilitating RB phosphorylation and inactivation. Indeed, cyclin D is overexpressed in many tumors because of amplification or translocation of the cyclin D1 gene. Mutational inactivation of genes encoding CDKIs also can drive the cell cycle by removing important brakes on cyclin/ CDK activity. As mentioned earlier, the CDKN2A gene, which encodes the CDK inhibitor p16, is an extremely common target of deletion or mutational inactivation in human tumors."
        },
        {
            "id": "Cell_Biology_Alberts_5041",
            "title": "Cell_Biology_Alberts",
            "content": "The key function of G1-Cdk complexes in animal cells is to activate a group of gene regulatory factors called the E2F proteins, which bind to specific DNA sequences in the promoters of a wide variety of genes that encode proteins required for S-phase entry, including G1/S-cyclins, S-cyclins, and proteins involved in DNA synthesis and chromosome duplication. In the absence of mitogenic stimulation, E2F-dependent gene expression is inhibited by an interaction between E2F and members of the retinoblastoma protein (Rb) family. When cells are stimulated to divide by mitogens, active G1-Cdk accumulates and phosphorylates Rb family members, reducing their binding to E2F. The liberated E2F proteins then activate expression of their target genes (Figure 17\u201361). This transcriptional control system, like so many other control systems that regulate the cell cycle, includes feedback loops that ensure that entry into the activation of transcription regulatory protein CYTOSOL"
        },
        {
            "id": "Pathology_Robbins_1247",
            "title": "Pathology_Robbins",
            "content": "RB: Governor of the Cell Cycle RB, a key negative regulator of the cell cycle, is directly or indirectly inactivated in most human cancers. The http://ebooksmedicine.net retinoblastoma gene (RB) was the first tumor suppressor gene to be discovered and is now considered the prototype of this family of cancer genes. As with many advances in medicine, the discovery of tumor suppressor genes was accomplished by the study of a rare disease\u2014in this case, retinoblastoma, an uncommon childhood tumor. Approximately 60% of retinoblastomas are sporadic, while the remaining ones are familial, the predisposition to develop the tumor being transmitted as an autosomal dominant trait. To account for the sporadic and familial occurrence of an identical tumor, Knudson, in 1974, proposed his now famous two-hit hypothesis, which in molecular terms can be stated as follows:"
        },
        {
            "id": "Pathology_Robbins_1253",
            "title": "Pathology_Robbins",
            "content": "This situation is changed on mitogenic signaling. Growth factor signaling leads to cyclin D expression and activation of cyclin D\u2013CDK4/6 complexes. The level of cyclin D-CDK4/6 activity is tempered by antagonists such as p16, which is itself subject to regulation by growth inhibitors such as TGF\u03b2 that serve to set a threshold for mitogenic responses. If the stimulus is sufficently strong, cyclin D-CDK4/6 complexes phosphorylate RB, inactivating the protein and releasing E2F to induce target genes such as cyclin E. Cyclin E/CDK complexes then stimulate DNA replication and progression through the cell cycle. When the cells enter S phase, they are committed to divide without additional growth factor stimulation. During the ensuing M phase, the phosphate groups are removed from RB by cellular phosphatases, regenerating the hypophosphorylated form of RB."
        },
        {
            "id": "Cell_Biology_Alberts_7004",
            "title": "Cell_Biology_Alberts",
            "content": "Ras-GEFs Ras guanine nucleotide exchange factors; stimulate the dissociation of GDP and the subsequent uptake of GTP from the cytosol, thereby activating Ras. Ras\u2013MAP-kinase signaling pathway Intracellular signaling pathway that relays signals from activated receptor tyrosine kinases to effector proteins in the cell including transcription regulators in the nucleus. Rb gene The gene that is defective in both copies in individuals with retinoblastoma; its protein product plays a central role in cell-cycle control. reading frame The phase in which nucleotides are read in sets of three to encode a protein. An mRNA molecule can be read in any one of three reading frames, only one of which will give the required protein. (Figure 6\u201349)"
        },
        {
            "id": "Pathoma_Husain_69",
            "title": "Pathoma_Husain",
            "content": "ii. Germline mutation results in Li-Fraumeni syndrome (2nd hit is somatic), characterized by the propensity to develop multiple types of carcinomas and sarcomas. C. Rb also regulates progression from G1 to S phase. 1. Rb \"holds\" the E2F transcription factor, which is necessary for transition to the S phase. 2. E2F is released when RB is phosphorylated by the cyclinD/cyclin-dependent kinase 4 (CDK4) complex. 3. Rb mutation results in constitutively free E2F, allowing progression through the cell cycle and uncontrolled growth of cells. 4. Both copies of Rb gene must be knocked out for tumor formation (Knudson twohit hypothesis). i. Sporadic mutation (both hits are somatic) is characterized by unilateral retinoblastoma (Fig. 3.1). 11. Germline mutation results in familial retinoblastoma (2nd hit is somatic), characterized by bilateral retinoblastoma and osteosarcoma. IV. REGULATORS OF APOPTOSIS"
        },
        {
            "id": "Cell_Biology_Alberts_4821",
            "title": "Cell_Biology_Alberts",
            "content": "Typically, in a population of cultured mammalian cells that are all proliferating rapidly but asynchronously, about 30\u201340% will be in S phase at any instant and become labeled by a brief pulse of BrdU. From the proportion of cells in such a population that are labeled, we can estimate the duration of S phase as a fraction of the whole cell-cycle duration. Similarly, from the proportion of cells in mitosis (the mitotic index), we can estimate the duration of M phase. Another way to assess the stage that a cell has reached in the cell cycle is by measuring its DNA content, which doubles during S phase. This approach is greatly facilitated by the use of fluorescent DNA-binding dyes and a flow cytometer, which allows the rapid and automatic analysis of large numbers of cells (Figure 17\u20138). We can use flow cytometry to determine the lengths of G1, S, and G2 + M phases, by measuring DNA content in a synchronized cell population as it progresses through the cell cycle."
        },
        {
            "id": "Cell_Biology_Alberts_6885",
            "title": "Cell_Biology_Alberts",
            "content": "G0 State of withdrawal from the eukaroytic cell-division cycle by entry into a quiescent digression from the G1 phase. A common, sometimes permanent, state for differentiated cells. G1 phase Gap 1 phase of the eukaryotic cell-division cycle, between the end of mitosis and the start of DNA synthesis. (Figure 17\u20134) G1-Cdk Cyclin\u2013Cdk complex formed in vertebrate cells by a G1-cyclin and the corresponding cyclin-dependent kinase (Cdk). (Table 17\u20131, p. 969) G1-cyclin Cyclin present in the G1 phase of the eukaryotic cell cycle. Forms complexes with Cdks that help govern the activity of the G1/S-cyclins, which control progression to S phase. G1/S-Cdk Cyclin\u2013Cdk complex formed in vertebrate cells by a G1/S-cyclin and the corresponding cyclin-dependent kinase (Cdk). (Figure 17\u201311 and Table 17\u20131, p. 969)"
        },
        {
            "id": "Pharmacology_Katzung_5880",
            "title": "Pharmacology_Katzung",
            "content": "Information on cell and population kinetics of cancer cells explains, in part, the limited effectiveness of most available anticancer drugs. A schematic summary of cell cycle kinetics is presented in Figure 54\u20132. This information is relevant to the mode of action, indications, and scheduling of cell cycle\u2013 specific (CCS) and cell cycle\u2013nonspecific (CCNS) drugs. Agents falling into these two major classes are summarized in Table 54\u20131. The Role of Drug Combinations With rare exceptions (eg, choriocarcinoma and Burkitt\u2019s lymphoma), single drugs are unable to cure cancers when they are in an advanced stage. In the 1960s and early 1970s, drug Synthesis of cellular components needed for DNA synthesis Replication of DNA genome"
        },
        {
            "id": "Pathology_Robbins_1252",
            "title": "Pathology_Robbins",
            "content": "To appreciate this crucial role of RB in the cell cycle, it is helpful to review the mechanisms that enforce the G1/S transition. The initiation of DNA replication (S phase) requires the activity of cyclin E/CDK2 complexes, and expression of cyclin E is dependent on the E2F family of transcription factors. Early in G1, RB is in its hypophosphorylated active form, and it binds to and inhibits the E2F family of transcription factors, preventing transcription of cyclin E. Hypophosphorylated RB blocks E2F-mediated transcription in at least two ways ( Fig. 6.20 ). First, it sequesters E2F, preventing it from interacting with other transcriptional activators. Second, RB recruits chromatin remodeling proteins, such as histone deacetylases and histone methyltransferases, which bind to the promoters of E2F-responsive genes such as cyclin E. These enzymes modify chromatin at the promoters to make DNA insensitive to transcription factors."
        },
        {
            "id": "Gynecology_Novak_6734",
            "title": "Gynecology_Novak",
            "content": "A phase II investigation of the aromatase inhibitor anastrozole showed minimal activity in an unselected subset of patients with advanced or recurrent endometrial cancer (364)."
        },
        {
            "id": "Gynecology_Novak_489",
            "title": "Gynecology_Novak",
            "content": "Genetic Control of the Cell Cycle Cellular proliferation must occur to balance normal cell loss and maintain tissue and organ integrity. This process requires the coordinated expression of many genes at discrete times during the cell cycle (3). In the absence of growth factors, cultured mammalian cells are arrested in the G0 phase. With the addition of growth factors, these quiescent cells pass through the so-called restriction point 14 to 16 hours later and enter the S phase 6 to 8 hours thereafter. The restriction point or G1/S boundary marks the point at which a cell commits to proliferation. A second checkpoint is the G2/M boundary, which marks the point at which repair of any DNA damage must be completed (4\u20137). To successfully complete the cell cycle, a number of cell division cycle (cdc) genes are activated."
        },
        {
            "id": "Cell_Biology_Alberts_5042",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 17\u201361 Mitogen stimulation of cell-cycle entry. as discussed in Chapter 15, mitogens bind to cell-surface receptors to initiate intracellular signaling pathways. One of the major pathways involves activation of the small gTpase Ras, which activates a map kinase cascade, leading to increased expression of numerous immediate early genes, including the gene encoding the transcription regulatory protein myc. myc increases the expression of many delayed-response genes, including some that lead to increased g1-Cdk activity (cyclin d\u2013 Cdk4), which triggers the phosphorylation of members of the Rb family of proteins. This inactivates the Rb proteins, freeing the gene regulatory protein E2F to activate the transcription of g1/s genes, including the genes for a g1/s-cyclin (cyclin E) and s-cyclin (cyclin a). The resulting g1/s-Cdk and s-Cdk activities further enhance Rb protein phosphorylation, forming a positive feedback loop. E2F proteins also stimulate the transcription of their own"
        },
        {
            "id": "Histology_Ross_469",
            "title": "Histology_Ross",
            "content": "The restriction point (or \u201cpoint of no return\u201d) is the most important checkpoint in the cell cycle. At this checkpoint, the cell self-evaluates its own replicative potential before deciding to either enter the S phase and the next round of cell division or to retire and leave the cell cycle. A cell that leaves the cycle in the G1 phase usually begins terminal differentiation by entering the GO phase (\u201cO\u201d stands for \u201coutside\u201d the cycle). Thus, the G1 phase may last for only a few hours (average 9 to 12 hours) in a rapidly dividing cell, or it may last a lifetime in a nondividing cell. This checkpoint is mediated by interactions between the retinoblastoma susceptibility protein (pRb) and a family of essential transcription factors (E2F) with target promoters. In normal cells, proper interaction between pRb and E2F turns off many genes and blocks cell-cycle progression. In the S phase, DNA is replicated."
        },
        {
            "id": "Pathology_Robbins_1261",
            "title": "Pathology_Robbins",
            "content": "Fig. 6.21 ). It occurs late in the G1 phase and is caused mainly by p53-dependent transcription of the CDKI gene CDKN1A (p21). The p21 protein inhibits cyclin\u2013CDK complexes and prevents phosphorylation of RB, thereby arresting cells in the G1 phase. Such a pause in cell cycling is welcome, because it gives the cells \u201cbreathing time\u201d to repair DNA damage. The p53 protein also induces expression of DNA damage repair genes. If DNA damage is repaired successfully, p53 upregulates transcription of MDM2, leading to its own destruction and relief of the cell cycle block. If the damage cannot be repaired, the cell may enter p53induced senescence or undergo p53-directed apoptosis."
        },
        {
            "id": "Cell_Biology_Alberts_7014",
            "title": "Cell_Biology_Alberts",
            "content": "retinoblastoma protein (Rb protein) Tumor suppressor protein involved in the regulation of cell division. Mutated in the cancer retinoblastoma, as well as in many other tumors. Its normal activity is to regulate the eukaryotic cell cycle by binding to and inhibiting the E2F proteins, thus blocking progression to DNA replication and cell division. (Figure 17\u201361) retroviral-like retrotransposons A large family of transposons that move themselves in and out of chromosomes by a mechanism similar to that used by retroviruses, being first transcribed into an RNA copy that is converted to DNA by reverse transcriptase then inserted elsewhere in the genome. (Table 5\u20134, p. 288) retrovirus RNA-containing virus that replicates in a cell by first making an RNA\u2013DNA intermediate and then a double-strand DNA molecule that becomes integrated into the cell\u2019s DNA. (Figure 5\u201362) reverse genetics Approach to discovering gene function that starts from the DNA (gene) and its protein product and then"
        },
        {
            "id": "Pharmacology_Katzung_5881",
            "title": "Pharmacology_Katzung",
            "content": "Synthesis of cellular components needed for DNA synthesis Replication of DNA genome FIGURE 54\u20132 Cell cycle and cancer. A conceptual depiction of the cell cycle phases that all cells\u2014normal and neoplastic\u2014must traverse before and during cell division. The percentages given represent the approximate percentage of time spent in each phase by a typical malignant cell; the duration of G1, however, can vary markedly. Many of the effective anti-cancer drugs exert their action on cells traversing the cell cycle and are called cell cycle-specific (CCS) drugs (see Table 54\u20131). A second group of agents called cell cycle-nonspecific (CCNS) drugs can sterilize tumor cells whether they are cycling or resting in the G0 compartment. CCNS drugs can kill both G0 and cycling cells (although cycling cells are more sensitive). TABLE 54\u20131 Cell cycle effects of major classes of anti-cancer drugs."
        },
        {
            "id": "Cell_Biology_Alberts_5542",
            "title": "Cell_Biology_Alberts",
            "content": "Figure 20\u201319 Mutation of the epidermal growth factor (EGF) receptor can make it active even in the absence of EGF, and consequently oncogenic. Only one of the possible types of activating mutations is illustrated here. NORMAL, HEALTHY INDIVIDUAL HEREDITARY RETINOBLASTOMA NONHEREDITARY RETINOBLASTOMA occasional cell inactivates one of its two good Rb genes excessive cell proliferation leading to retinoblastoma excessive cell proliferation leading to retinoblastoma"
        }
    ],
    "scores": [
        0.02922139729678279,
        0.026333142802319343,
        0.02595699917898194,
        0.025939598335004404,
        0.025195081936737217,
        0.024846642272922943,
        0.024642869518512744,
        0.024114659651632803,
        0.02389556130563325,
        0.02362743425948896,
        0.021468485794114443,
        0.021176715158354058,
        0.02079147139413359,
        0.019302594537704255,
        0.018961512076266174,
        0.01886960391633289,
        0.018637309292649097,
        0.01852010631912887,
        0.018447998646018447,
        0.01761642156862745,
        0.017139090309822018,
        0.017105263157894735,
        0.017094017094017096,
        0.016892373485388454,
        0.016666666666666666,
        0.016464237516869096,
        0.016155299329033937,
        0.016035959424163276,
        0.01601640079441348,
        0.015919959728165116,
        0.015847665847665848,
        0.015193747608897632
    ]
}